Fanconi Anemia clinical trials
16 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab
- HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
- TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
- MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
- Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
- Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
- Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
- Familial Investigations of Childhood Cancer Predisposition
- Investigation of the Genetics of Hematologic Diseases
- Cancer in Inherited Bone Marrow Failure Syndromes
- Role of Acetaldehyde in the Development of Oral Cancer
- Prenatal Transplantation for Fetuses With Fanconi Anemia
- Clinical Genetics Branch Eligibility Screening Survey
- Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Fanconi Anemia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.